EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Handshake on blue background

FDA greenlights UCB’s IL-17 inhibitor for HS

The novel IL-17A and IL-17F inhibitor has been approved the treatment of moderate to severe hidradenitis suppurativa, a chronic and painful skin disease.
world in hands

Novartis takes the top spot in 2024 Access to Medicine Index

Novartis has claimed the top spot in the 2024 Access to Medicine Index, displacing GSK after 16 consecutive years at the top.  

Revisto raises $4m to streamline pharma compliance with AI

Revisto has raised $4m in seed funding to simplify the pharmaceutical industry’s marketing compliance processes using AI.
stamp of approval

FDA approves first gene therapy delivered directly to the brain

Discover how PTC Therapeutics’ treatment for a rare and fatal genetic disorder called aromatic l-amino acid decarboxylase (AADC) deficiency reached approval

Europe’s pharma R&D productivity grows, but falls behind US and China

Europe’s pharmaceutical research and development sector is in a tight spot as new data reveals that R&D spending isn’t keeping up with global competitors.
Coin stacks

AstraZeneca bets big on US, pledges to invest $3.5bn

Discover how AZ’s capital investment is set to expand its US research and manufacturing capabilities by the end of 2026.
Red arrow tracking bar chart that is ascending in height

BMS, Gilead and Sanofi lead Q3 2024 market cap growth

The third quarter of 2024 brought a mix of gains and modest declines for the pharmaceutical industry’s top players, according to GlobalData.

FDA nod for Johnson & Johnson’s atrial fibrillation device

Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.